(Q33389572)
Statements
1 reference
Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Res (English)
1 reference
Patrick Schöffski
1 reference
Stefan Sleijfer
1 reference
Etienne Brain
1 reference
Jean-Pascal Machiels
1 reference
Pascal Wolter
1 reference
Christel Fontaine
1 reference
Gerd Munzert
1 reference
Holger Fritsch
1 reference
Gertraud Hanft
1 reference
Claire Aerts
1 reference
Jérome Rapion
1 reference
Anouk Allgeier
1 reference
Jan Bogaerts
1 reference
Denis Lacombe
1 reference
1 reference
Identifiers
1 reference